Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd
SSE:603707.SS
11.31 (CNY) • At close June 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) CNY.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 1,024.384 | 1,209.808 | 1,388.512 | 658.553 | 493.553 | 364.162 | 434.805 | 73.126 | 265.693 | 432.42 | 594.35 | 310.328 |
| Short Term Investments
| 1,055.442 | 681.989 | 1.3 | 259.799 | 845.794 | 56.636 | -2.047 | -2.305 | -2.39 | -2.563 | 1.637 | -1.195 |
| Cash and Short Term Investments
| 2,079.827 | 1,891.797 | 1,389.812 | 918.352 | 1,339.347 | 420.797 | 434.805 | 73.126 | 265.693 | 432.42 | 595.987 | 310.328 |
| Net Receivables
| 1,193.508 | 1,002.568 | 974.109 | 897.752 | 788.106 | 407.749 | 190.2 | 0 | 80.12 | 0 | 0 | 92.597 |
| Inventory
| 3,674.966 | 4,158.269 | 5,615.601 | 4,894.25 | 4,457.424 | 3,273.857 | 1,951.506 | 1,293.919 | 672.132 | 281.717 | 326.335 | 443.242 |
| Other Current Assets
| 97.589 | 208.971 | 314.542 | 219.477 | 183.214 | 175.909 | 261.505 | 72.948 | 35.448 | 8.234 | 238.221 | 100.844 |
| Total Current Assets
| 7,045.89 | 7,261.604 | 8,294.065 | 6,929.83 | 6,768.091 | 4,288.776 | 2,838.015 | 2,191.875 | 1,053.393 | 965.701 | 1,219.692 | 854.414 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1,197.253 | 1,245.827 | 1,197.598 | 827.42 | 532.831 | 481.594 | 471.228 | 402.658 | 398.849 | 302.742 | 271.795 | 214.071 |
| Goodwill
| 129.51 | 127.606 | 125.478 | 114.868 | 117.556 | 125.687 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 796.082 | 467.149 | 212.195 | 199.931 | 159.124 | 125.032 | 73.643 | 44.671 | 45.46 | 17.14 | 16.084 | 16.373 |
| Goodwill and Intangible Assets
| 925.592 | 594.755 | 337.673 | 314.799 | 276.68 | 250.719 | 73.643 | 44.671 | 45.46 | 17.14 | 16.084 | 16.373 |
| Long Term Investments
| -972.182 | 72.478 | 60.303 | -233.414 | -842.535 | -55.7 | 5.88 | 5.243 | 4.967 | 5.372 | 1.888 | 4.852 |
| Tax Assets
| 203.247 | 348.404 | 101.474 | 34.536 | 21.646 | 13.271 | 4.612 | 4.478 | 4.367 | 4.4 | 3.959 | 2.361 |
| Other Non-Current Assets
| 1,110.149 | 1.196 | 18.991 | 343.716 | 963.646 | 99.759 | 8.946 | 45.835 | 15.667 | 2.04 | 26.694 | 65.189 |
| Total Non-Current Assets
| 2,464.06 | 2,262.66 | 1,716.038 | 1,287.058 | 952.269 | 789.643 | 564.309 | 502.885 | 469.31 | 331.695 | 320.42 | 302.846 |
| Total Assets
| 9,509.95 | 9,524.264 | 10,010.103 | 8,216.888 | 7,720.36 | 5,078.419 | 3,402.323 | 2,694.76 | 1,522.703 | 1,297.396 | 1,540.112 | 1,157.26 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 495.664 | 537.74 | 505.12 | 458.874 | 362.59 | 487.672 | 426.183 | 209.632 | 14.248 | 27.106 | 40.438 | 9.571 |
| Short Term Debt
| 1,236.046 | 1,566.802 | 1,956.863 | 1,570.663 | 2,147.432 | 1,368.366 | 290.623 | 322.876 | 119.964 | 101.055 | 392.8 | 87.104 |
| Tax Payables
| 16.582 | 29.31 | 7.283 | 31.805 | 21.884 | 31.303 | 20.682 | 20.9 | 3.05 | 7.94 | 18.564 | 5.304 |
| Deferred Revenue
| 0 | 0 | 38.223 | 220.769 | 142.5 | 138.554 | 20.682 | 53.406 | 20.505 | 27.992 | 39.555 | 15.33 |
| Other Current Liabilities
| 316.162 | 952.41 | 197.165 | -15.655 | 260.08 | 145.968 | 153.956 | 53.222 | 35.32 | 46.98 | 34.452 | 22.985 |
| Total Current Liabilities
| 2,064.454 | 3,086.262 | 2,704.654 | 2,266.456 | 2,806.063 | 2,033.31 | 947.411 | 606.631 | 172.582 | 183.082 | 486.254 | 124.964 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 828.268 | 519.433 | 1,013.305 | 474.581 | 1,125.418 | 6.17 | 6.17 | 6.17 | 6.17 | 6.17 | 6.17 | 6.17 |
| Deferred Revenue Non-Current
| 84.626 | 0 | 84.987 | 65.506 | 38.149 | 34.845 | 27.63 | 29.696 | 29.341 | 15.468 | 15.587 | 7.778 |
| Deferred Tax Liabilities Non-Current
| 38.275 | 37.334 | 39.987 | 1.418 | 0 | 6.17 | -27.63 | -0 | -29.341 | -15.468 | 0.246 | 0 |
| Other Non-Current Liabilities
| 6.17 | 82.738 | 0 | 6.17 | 6.17 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities
| 957.34 | 639.505 | 1,138.279 | 547.675 | 1,169.737 | 41.015 | 33.8 | 35.866 | 35.511 | 21.638 | 22.003 | 13.948 |
| Total Liabilities
| 3,021.794 | 3,725.767 | 3,842.933 | 2,814.131 | 3,975.8 | 2,074.325 | 981.211 | 642.496 | 208.094 | 204.72 | 508.257 | 138.912 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.151 | 0 |
| Common Stock
| 1,615.635 | 1,616.649 | 1,617.075 | 1,243.6 | 934.161 | 718.474 | 552.426 | 423.5 | 360 | 360 | 360 | 360 |
| Retained Earnings
| 3,668.425 | 3,062.713 | 3,438.074 | 2,765.493 | 2,229.301 | 1,713.832 | 1,241.189 | 905.588 | 618.584 | 408.83 | 356.822 | 346.435 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 72.504 | 545.792 | 406.595 | 417.33 | 186.359 | 119.386 | 106.417 | 79.511 | 67.332 | -0.151 | 0 |
| Other Total Stockholders Equity
| 1,207.61 | 1,050.101 | 1,115.493 | 1,368.829 | 399.185 | 534.187 | 627.498 | 723.176 | 336.025 | 323.846 | 315.185 | 310.919 |
| Total Shareholders Equity
| 6,491.67 | 5,801.967 | 6,170.641 | 5,377.921 | 3,722.439 | 2,966.493 | 2,421.113 | 2,052.264 | 1,314.609 | 1,092.676 | 1,031.855 | 1,017.354 |
| Total Equity
| 6,488.157 | 5,798.497 | 6,167.17 | 5,402.757 | 3,744.56 | 3,004.094 | 2,421.113 | 2,052.264 | 1,314.609 | 1,092.676 | 1,031.855 | 1,018.348 |
| Total Liabilities & Shareholders Equity
| 9,509.95 | 9,524.264 | 10,010.103 | 8,216.888 | 7,720.36 | 5,078.419 | 3,402.323 | 2,694.76 | 1,522.703 | 1,297.396 | 1,540.112 | 1,157.26 |